Literature DB >> 2422081

Effects of nerve compression on fast axonal transport in streptozotocin-induced diabetes mellitus. An experimental study in the sciatic nerve of rats.

L B Dahlin, K F Meiri, W G McLean, B Rydevik, J Sjöstrand.   

Abstract

The hypothesis that nerves in diabetes mellitus exhibit an increased susceptibility to compression was experimentally tested. Inhibition of fast axonal transport was induced by local compression in sciatic nerves of rats with streptozotocin-induced diabetes mellitus. Fast anterograde axonal transport was measured after application of 3H-leucine to the motor neurone cell bodies in the spinal cord. The sciatic nerve was subjected to local, graded compression in vivo by a small compression chamber. The amount of accumulation of proteins was quantified by calculation of a transport block ratio. Compression at 30 mm Hg for 3 h induced a significantly greater (p less than 0.05) accumulation of axonally transported proteins at the site of compression in nerves of diabetic animals (transport block ratio: 1.01 +/- 0.35; n = 7) than in nerves of controls (0.67 +/- 0.16; n = 7). Accumulation was significantly higher in ligature experiments of both control (1.34 +/- 0.44; n = 8; p less than 0.01) and diabetic animals (1.45 +/- 0.30; n = 8; p less than 0.05), indicating that the block of transport in compressed nerves was incomplete. Neither sham compressed diabetic (0.50 +/- 0.09; n = 6) nor control (0.49 +/- 0.11; n = 6) nerves showed any block of axonal transport. The possible causes of the increased inhibition of fast axonal transport in diabetic rats are discussed. The results indicate that diabetes may lead to an increased susceptibility of peripheral nerves to compression.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422081     DOI: 10.1007/bf02427090

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

1.  Peripheral nerve conduction in diabetic neuropathy.

Authors:  R W GILLIATT; R G WILLISON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-02       Impact factor: 10.154

2.  Permeability of the blood-nerve barrier in the streptozotocin-diabetic rat.

Authors:  J Jakobsen; L Malmgren; Y Olsson
Journal:  Exp Neurol       Date:  1978-06       Impact factor: 5.330

3.  Axoplasmic transport of labeled proteins in rat ventral motoneurons.

Authors:  R J Lasek
Journal:  Exp Neurol       Date:  1968-05       Impact factor: 5.330

4.  Regeneration of motor axons in the rat sciatic nerve studied by labeling with axonally transported radioactive proteins.

Authors:  D S Forman; R A Berenberg
Journal:  Brain Res       Date:  1978-11-10       Impact factor: 3.252

Review 5.  Defects of axonal transport in diabetes mellitus--a possible contribution to the aetiology of diabetic neuropathy.

Authors:  D R Tomlinson; J H Mayer
Journal:  J Auton Pharmacol       Date:  1984-03

6.  Fast axonal transport and amine levels.

Authors:  M A Bisby
Journal:  Nature       Date:  1976-11-25       Impact factor: 49.962

Review 7.  The axonopathy of diabetic neuropathy.

Authors:  P Sidenius
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

8.  Increased endoneurial fluid pressure in galactose neuropathy.

Authors:  R R Myers; M L Costello; H C Powell
Journal:  Muscle Nerve       Date:  1979 Jul-Aug       Impact factor: 3.217

9.  Decreased axonal transport of structural proteins in streptozotocin diabetic rats.

Authors:  J Jakobsen; P Sidenius
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

10.  Permeability of intraneural microvessels and perineurium following acute, graded experimental nerve compression.

Authors:  B Rydevik; G Lundborg
Journal:  Scand J Plast Reconstr Surg       Date:  1977
View more
  11 in total

1.  Symptomatic focal mononeuropathies in diabetic patients: increased or not?

Authors:  Elefterios Stamboulis; Demetris Vassilopoulos; Nikolaos Kalfakis
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

Review 2.  Focal and multifocal neuropathies.

Authors:  Rayaz A Malik
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

3.  Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.

Authors:  L B Dahlin; D R Archer; W G McLean
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

4.  Pressure-induced inhibition of fast axonal transport of proteins in the rabbit vagus nerve in galactose neuropathy: prevention by an aldose reductase inhibitor.

Authors:  W G McLean
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

5.  Molecular and pathological studies in the posterior interosseous nerve of diabetic and non-diabetic patients with carpal tunnel syndrome.

Authors:  Moaz A Mojaddidi; Mohammed S Ahmed; Razwan Ali; Maria Jeziorska; Ahmed Al-Sunni; Niels O B Thomsen; Lars B Dahlin; Rayaz A Malik
Journal:  Diabetologia       Date:  2014-05-28       Impact factor: 10.122

6.  A study of motor and sensory evoked potentials in chronic cauda equina compression of the dog.

Authors:  N H Kim; I H Yang
Journal:  Eur Spine J       Date:  1996       Impact factor: 3.134

7.  Effect of diabetes on the enzymes of the cholinergic system of the rat brain.

Authors:  Z Z Wahba; K F Soliman
Journal:  Experientia       Date:  1988-09-15

Review 8.  Biologic Basis of Nerve Decompression Surgery for Focal Entrapments in Diabetic Peripheral Neuropathy.

Authors:  John Sessions; D Scott Nickerson
Journal:  J Diabetes Sci Technol       Date:  2014-02-27

9.  Surgical decompression of painful diabetic peripheral neuropathy: the role of pain distribution.

Authors:  Chenlong Liao; Wenchuan Zhang; Min Yang; Qiufeng Ma; Guowei Li; Wenxiang Zhong
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

10.  Diabetes mellitus as a risk factor for compression neuropathy: a longitudinal cohort study from southern Sweden.

Authors:  Mattias Rydberg; Malin Zimmerman; Anders Gottsäter; Peter M Nilsson; Olle Melander; Lars B Dahlin
Journal:  BMJ Open Diabetes Res Care       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.